Matthew J During

Title: Matthew J During: Innovator in Neurological Disease Treatment

Introduction

Matthew J During is a notable inventor based in Rowayton, CT (US). He has made significant contributions to the field of neurology, particularly in the treatment of neurological diseases. His innovative approach focuses on increasing brain concentrations of kynurenic acid to alleviate the effects of these diseases.

Latest Patents

Matthew J During holds a patent for the treatment of neurological diseases by increasing brain concentrations of kynurenic acid. This patent addresses conditions such as Huntington's disease, which is exacerbated by the toxic effects of excitatory amino acids. The patent outlines a method of administering metabolic precursors of kynurenic acid, including kynurenine and tryptophan, to affected individuals. Research indicates that patients with Huntington's disease have lower levels of kynurenic acid in their brains compared to healthy individuals. This decrease is associated with the formation of lesions in the brain, as kynurenic acid acts as an inhibitor of excitatory amino acid interactions at their receptors.

Career Highlights

Matthew J During is affiliated with The General Hospital Corporation, where he continues to advance his research and innovations in neurology. His work has the potential to significantly impact the treatment of neurological disorders, providing hope for many patients.

Collaborations

Matthew collaborates with esteemed colleagues, including Andrew Freese and M Flint Beal, to further enhance the research and development of treatments for neurological diseases.

Conclusion

Matthew J During's innovative work in the treatment of neurological diseases showcases his dedication to improving patient outcomes through scientific research. His contributions to the field are invaluable and highlight the importance of continued innovation in medical science.